christopher moertel

Professor of Pediatrics, University of Minnesota

[christopher moertel @moert001]

@SCOTUSblog So how does this jibe with the SCOTUS claim that race is not a factor in elections. Race counts in one place, but not another? Somebody help me clarify the principals that are being applied.

[christopher moertel @moert001]

https://t.co/pUoZMGDHv4

[christopher moertel @moert001]

@spectatorindex Definitely what the American people want! (Not)

[christopher moertel @moert001]

At the Brain Cancer Symposium in Canada, sharing data from OX2 Therapeutics. Thank you ⁦@DIPGCollab⁩

[christopher moertel @moert001]

New news from the University of Minnesota Brain Tumor Program https://t.co/bJHALJzd1p

[christopher moertel @moert001]

@DrOzCMS You know, but it has not been said loudly enough, the payers and especially the pharmacy benefit managers,have done more to make drugs less affordable than any drug company. Also - making pharma charge less in the US will then make life saving drugs unaffordable in the 3rd world.

[christopher moertel @moert001]

I'm excited to be part of this upcoming live discussion on MEK Inhibitors in Neurofibromatosis Type 1 presented by @cec_onc! Tune in online on 5/8 at 12:15p ET & earn 1.0 free #CME/CE credit ➡️ https://t.co/j3raRC5vgY #MedX #MedEd

[christopher moertel @moert001]

More on the ReNeu trial of mirdametinib for Neurofibromatosis, type 1 https://t.co/HE0apMXnN0

[christopher moertel @moert001]

@GopherFootball Shouldn’t have ever been an extra point - refs screw gophers again.

[christopher moertel @moert001]

@GopherFootball refs screw gophers again

[christopher moertel @moert001]

I hope that these data will help to bring mirdametinib to people living with neurofibromatosis, type 1. Thank you to SpringWorks Therapeutics, my co-authors, and the patients and families who contributed their time and effort to making this clinical trial successful.

[christopher moertel @moert001]

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma | Journal of Clinical Oncology https://t.co/Wn2Fnjuom0

I am honored to be lead author on this publication.

[christopher moertel @moert001]

@GopherMBB @CoachBenJohnson Great Win! Thanks for the great pre-game talk

[christopher moertel @moert001]

#dipgcollaborative

[christopher moertel @moert001]

#dipgcollaborative Matt Dun innovative researcher of the year

[christopher moertel @moert001]

#dipgcollaborative in Lexington, Kentucky. Great folks, great science!

[christopher moertel @moert001]

@JonoCowgill the decision to take down tennis nets (!) is ridiculous, paternalistic and wrong.